Wide Ranks

MYO

Myomo Inc.

5.22

Top Statistics
Market Cap 157 M Forward PE -92.11 Revenue Growth 81.30 %
Current Ratio 2.10 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -33.22 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -18.36 Enterprise / Revenue 6.00 Price To Sales Trailing12 Months 6.26
Profitability
Profit Margins -33.22 % Operating Margins -10.40 %
Balance Sheet
Total Cash 6 M Total Cash Per Share 0.2190 Total Debt 234629
Total Debt To Equity 2.52 Current Ratio 2.10 Book Value Per Share 0.3070
All Measures
Short Ratio 508.00 % Message Board Id finmb_26981670 Shares Short Prior Month 1 M
Return On Equity -0.8254 City Boston Uuid 4c314810-af16-37cf-bac3-e0eafa8a7696
Previous Close 5.27 First Trade Date Epoch Utc 1 B Book Value 0.3070
Beta 1.55 Total Debt 234629 Volume 186749
Price To Book 17.00 Last Split Date 1 B Fifty Two Week Low 2.51
Total Cash Per Share 0.2190 Total Revenue 25 M Shares Short Previous Month Date 1 B
Target Median Price 7.25 Max Age 86400 Recommendation Mean 1.33
Sand P52 Week Change 0.3133 Operating Margins -10.40 % Target Mean Price 7.33
Net Income To Common -8383752 Ask 5.50 Short Percent Of Float 0.0296
Implied Shares Outstanding 30 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 205260 Average Volume10days 205260 Total Cash 6 M
Next Fiscal Year End 1 B Revenue Per Share 0.8350 Held Percent Insiders 0.1304
Ebitda Margins -32.70 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 5.27 Target Low Price 6.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.18 Open 5.25
Free Cashflow -6195640 State MA Dividend Yield 0.00 %
Return On Assets -0.3145 Time Zone Short Name EST Trailing Eps -0.2300
Day Low 5.08 Address1 137 Portland Street Shares Outstanding 30 M
Price Hint 2 Target High Price 9.00 Website https://myomo.com
52 Week Change 0.6839 Average Volume 159740 Forward Eps -0.0500
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 148.10 %
Last Split Factor 1:30 Regular Market Day High 5.39 Is_sp_500 False
Profit Margins -33.22 % Debt To Equity 2.52 Fifty Two Week High 5.64
Day High 5.39 Shares Short 860095 Regular Market Open 5.25
Industry Key medical-devices Bid 5.06 Earnings Growth 0.00 %
Enterprise To Revenue 6.00 Revenue Growth 81.30 % Shares Percent Shares Out 0.0284
Operating Cashflow -9011376 Currency USD Time Zone Full Name America/New_York
Market Cap 157 M Is_nasdaq_100 False Zip 02114
Quote Type EQUITY Industry Medical Devices Long Name Myomo, Inc.
Regular Market Day Low 5.08 Held Percent Institutions 0.5135 Current Price 5.22
Address2 4th Floor Enterprise To Ebitda -18.36 Financial Currency USD
Current Ratio 2.10 Gross Margins 70.03 % Industry Disp Medical Devices
Number Of Analyst Opinions 6 Country United States Float Shares 15 M
Two Hundred Day Average 3.81 Enterprise Value 151 M Price To Sales Trailing12 Months 6.26
Forward PE -92.11 Regular Market Volume 186749 Ebitda -8252326
Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally.

The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.

It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device.

Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders.

The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors.

Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.